A 2025 Nature Cancer study demonstrated that deletion of NDUFS4 in mouse models of melanoma and BC increased mitochondrial acetyl-CoA production, enhanced MHC-I antigen presentation, and sensitized tumors to T-cell-mediated cytotoxicity and checkpoint blockade [20]. This evidence concerns the gene NDUFS4 and melanoma.